Keri Stalker, MBA
Keri is Conscience’s Director of Operations. Her expertise is in enabling cutting-edge science with operational excellence. Beginning in the early days of the Human Genome Project, she worked at the Broad Institute of Harvard and MIT with an international consortium to apply high-throughput approaches to genome sequencing and analysis in an open science environment. She […]
Dakota Treleaven
Dakota is the Operations Manager for CACHE at Conscience. She is passionate about advancing neuroscience, promoting open science and improving clinical care for patients. She is a highly organized problem solver determined to do her part in making science open and accessible to everyone. Dakota has a diverse background, holding a Master in Neuroscience, Bachelor’s […]
Sajjad Nakshab
Sajjad Nakshab is the Senior Financial Analyst at Conscience, bringing over ten years of experience across the financial value chain. He has worked with a variety of organizations, including prominent investment banks in Europe and the US, as well as a boutique consultancy firm in Qatar. His expertise spans financial analysis, financial reporting, investment appraisals, […]
Resham Chhabra, PhD
Resham Chhabra is Conscience’s Program Manager for Drug Discovery and Development. She holds a Ph.D. in Molecular Medicine with a focus on Neuroscience and Nanomedicine from Ulm University, Germany, and an M.Sc. in Neuroscience with a specialization in Neurodegeneration from King’s College London, England. Her research covered a broad spectrum of experimental work, from diagnostic tools […]
Estrid Jakobsen, PhD
Estrid is Conscience’s Communications Lead. She is passionate about science communication and helping researchers make their findings open and accessible to everyone. Estrid has over twelve years of education and experience as a neuroscientist and holds a PhD from the Max Planck Institute for Human Cognitive and Brain Sciences in Leipzig, Germany. Her time as […]
Anne Fortier, PhD
Anne Fortier is Conscience`s Vice President of Drug Discovery and Development. She is a drug hunter, a strong problem-solving person and an accomplished project leader with a track record of successfully delivering first-in-class small molecule agents, including Inaxaplin. She holds a PhD in Biochemistry from McGill University`s Centre for the Study of Host Resistance and […]
Lauriane Gorce
Lauriane Gorce is the Senior Manager for Partnerships. She is curious, courageous and caring. She’s on a mission to explore how innovations (what’s new) can bring true progress to human beings and to our planet (what’s better). She has worked in Europe, Asia and North America, opening black boxes in various sectors: data governance and […]
Dylan Roskams-Edris, JD
Dylan is Conscience’s Network Lead for Education and Events. He started with a B.Sc. in Neuroscience from McGill—including stints in labs working with yeast, mice, and human data—moved on to a Masters of Health Ethics from Memorial University of Newfoundland, and ended his educational peregrination with a JD from Schulich School of Law at Dalhousie, […]
Mari Moreshead
Mari is Conscience’s Chief of Staff, Program Manager, and Board Secretary. She is an exceptionally effective and detail oriented person who enjoys nothing more than getting things done. At organizations such as Creative Commons, Mozilla, and various other small organizations, she’s held significant roles such as Chief of Staff, Executive Assistant, and Director of People […]
Richard Gold, LLM, SJD
Richard Gold, LLM, SJD, is a professor at McGill University specializing in finding novel incentives to advance drug discovery more efficiently, Director of McGill’s Center for Intellectual Property Policy, and Senior Fellow at the Centre for International Governance Innovation. His work spans over two decades in universities, before courts, and with international organizations on issues […]
Jeeshan Ifthikar, CFA, CPA
Jeeshan leads Conscience’s financial functions. Starting his career at KPMG, Jeeshan has over a decade of well-rounded experience working in various industries gaining expertise in financial analysis and accounting, development of operational and financial strategy, assessment of expansion opportunities, and risk management. Prior to joining Conscience, Jeeshan held positions with the Ontario Medical Association and […]
Aled Edwards, SG, PhD, OC
Aled Edwards, SG, PhD, OC, is the Temerty Nexus Chair of Health Innovation and Technology at the University of Toronto, and Chief Executive of the Structural Genomics Consortium (SGC), which is perhaps the longest running and most well-known pre-competitive partnership in drug discovery. The SGC has been a pioneer in open science and does not […]
